Theresa Werner, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Mersana Therapeutics
    Topic: 
    Advisor for clincial trial
    Date added: 
    09/29/2022
    Relationship end date: 
    05/01/2022
Return to 2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes